James and Esther King Biomedical Research Program
Limited submission
The James and Esther King Biomedical Research Program funds Florida-based research on prevention, diagnosis, and treatment of major tobacco-related diseases, led by the Florida Department of Health.
Funder: Florida Department of Health
Due Dates: September 2, 2026: Letter of Intent (LOI) deadline (required) | October 21, 2026: Full application submission deadline
Funding Amounts: Up to $1.5M (Clinical Trials/Research Infrastructure, 36–48 months); other categories: $100K–$750K (6–36 months); indirect costs capped at 15%.
Summary: Supports Florida-based research into prevention, diagnosis, treatment, and cure of major diseases (especially tobacco-related cancer, cardiovascular disease, stroke, pulmonary disease).
Key Information: LOI is required and must be submitted via the online portal by Noon ET to access the full application.
Description
The James and Esther King Biomedical Research Program, administered by the Florida Department of Health, funds investigator-initiated biomedical research projects that address major health concerns for Floridians, with a strong emphasis on diseases linked to tobacco use—including cancer, cardiovascular disease, stroke, and pulmonary disease. The program aims to advance prevention, diagnosis, treatment, and cure of these diseases, foster biomedical innovation, enhance research infrastructure, and stimulate Florida’s biomedical sector.
Research priorities include projects that reduce disease morbidity and mortality, improve screening and accuracy, address treatment resistance, evaluate tobacco use prevention programs, investigate electronic cigarette health effects, and encourage technology transfer and commercialization. The program supports a wide range of research categories, from discovery science to clinical trials and infrastructure development.
